Read this article:
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Category Archives: Global News Feed
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
Continued here:
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
Read more from the original source:
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of…
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Read the original here:
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic…
Junshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGA
Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit
Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental…
Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference
Continue reading here:
Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Go here to see the original:
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards
See the original post here:
Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards